Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pancreatic cancer, adult × ensituximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2 Rectal Neoplasms 1 Pancreatic cancer, adult 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Pancreatic Ductal 1

Interventions

Gemcitabine 3 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 napabucasin 1 irinotecan sucrosofate 1 ensituximab 1 Taxes 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Hematologic Tests 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01834235 2025-05-07

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Precision Biologics, Inc

Phase 1/2 Terminated

81 enrolled 13 charts

Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡